Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00978796 · ClinicalTrials.gov registry record · Phase 4
Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00978796 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 20 participants.
The verdict
NCT00978796, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of sitagliptin on glucose variability both after meals and overnight in adult patients with type 1 diabetes.
Interventions
- DRUG Sitagliptin
- DRUG Sugar Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00978796
The ClinicalTrials.gov registry entry for NCT00978796 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sitagliptin is the first listed.
NCT00978796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00978796 about?
NCT00978796 is a clinical study titled "Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes". The purpose of this study is to determine the effects of sitagliptin on glucose variability both after meals and overnight in adult patients with type 1 diabetes.
What is the current status of trial NCT00978796?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00978796?
The interventions under investigation include: Sitagliptin (DRUG), Sugar Pill (DRUG).
Who is sponsoring clinical trial NCT00978796?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.